AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA-licensed anthrax vaccine supplied to Taiwan.

Vaccine Weekly

| March 31, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAR 31 - (NewsRx.com & NewsRx.net) -- BioPort Corporation announced the sale of U.S. Food & Drug Administration (FDA)-licensed anthrax vaccine, BioThrax, to the Taiwanese government, marking the company's entry into the commercial market with its flagship product.

"There is a significant world-wide demand for anthrax vaccine for the protection of both military and civilian populations, including first responders," Bob Kramer, the company's president, said. "Our primary focus continues to be making vaccine available for the protection of U.S. service members and our citizens. At the same time, we are responding to a number of U.S. allies interested in obtaining the vaccine."

Officials in Taiwan will used the anthrax vaccine to immunize laboratory workers and to create a stockpile for emergency use.

In January, BioPort announced a $245-million contract with the U.S. Department of Defense for the continued supply of BioThrax in support of the pentagon's military vaccination program. Since 1998, more than one million service members ...

Related articles from newspapers, magazines, journals, and more
Safety profile of anthrax vaccine for U.S. soldiers in Korea determined.
Newspaper article from: Vaccine Weekly January 14, 2004 700+ words
...safety profile of the anthrax vaccine for U.S. soldiers...safety profile of anthrax vaccine for U.S. soldiers...subject areas of Anthrax Vaccine, Vaccine Safety...article was prepared by Vaccine Weekly editors from staff...
Serological correlate of protection in rabbits for anthrax vaccine identified.
Newspaper article from: Vaccine Weekly March 24, 2004 700+ words
...for a recombinant anthrax vaccine. According to a...for a recombinant anthrax vaccine. Vaccine, 2004...subject areas of Anthrax Vaccine, Vaccine Development...article was prepared by Vaccine Weekly editors from staff...
Flow cytometric assay for responses to anthrax vaccine developed.
Newspaper article from: Vaccine Weekly January 21, 2004 700+ words
...responses induced by the anthrax vaccine." Shinn and her...cellular responses to anthrax vaccine. J Immunol Method...subject areas of Anthrax Vaccine, Biowarfare, Bacteriology...article was prepared by Vaccine Weekly editors from staff...
Lymphocytic vasculitis associated with anthrax vaccine.
Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...associated with the anthrax vaccine is reported." Muniz...associated with the anthrax vaccine: Case report and...subject areas of Anthrax Vaccine, Vaccine Safety...article was prepared by Vaccine Weekly editors from staff...
Proposal submitted for production of up to 75 million doses of anthrax vaccine.
Newspaper article from: Vaccine Weekly May 26, 2004 700+ words
...of its recombinant anthrax vaccine to the U.S. strategic...develop its recombinant anthrax vaccine candidate. The contracts...article was prepared by Vaccine Weekly editors from staff...Copyright 2004, Vaccine Weekly via NewsRx.com...
Guardsman who refused anthrax vaccine discharged from Army.
Newspaper article from: Vaccine Weekly April 21, 2004 700+ words
...National Guard members based in Cincinnati were discharged for refusing the vaccinations. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Anthrax vaccine phase II trial begins.
Newspaper article from: Vaccine Weekly May 12, 2004 700+ words
...address the need for an anthrax vaccine that has an improved...existing licensed anthrax vaccine. The approved dosing...currently licensed anthrax vaccine in the United States...article was prepared by Vaccine Weekly editors from staff...
New type of anthrax vaccine moves into larger-scale trial.
Newspaper article from: Vaccine Weekly May 12, 2004 700+ words
...new investigational anthrax vaccine developed by VaxGen...develop an improved anthrax vaccine. In humans, anthrax...Although the current anthrax vaccine can prevent anthrax...article was prepared by Vaccine Weekly editors from staff...
For more facts and information, see all results

Source: HighBeam Research, FDA-licensed anthrax vaccine supplied to Taiwan.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA